ODX.L Share News (ODX)
ODX Share
ODX Share
ODX Share
ODX Share
ODX
ODX Share
ODX Broker
ODX Directors
ODX Financial
ODX
ODX Short
ODXThu, 02nd Jul 2020 10:32
Omega Diagnostics Group PLC - London-focused medical diagnostics firm - Reports its ELISA antibody test for Covid-19 approved for use in India. Permission to commence sales is conditional on Omega submitted "supporting technical data", though the company is optimistic.
Current stock price: 42.65 pence
Year-to-date change: up roughly threefold from 14.22p on January 2
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
AIM WINNERS & LOSERS: Shanta reserves impress; XLMedia casino arm hurt
Read moreOmega Diagnostics shares drop after confirming fundraising talks
Read moreAIM WINNERS & LOSERS: Omega Diagnostics falls; Venture Life sales up
Read moreEXECUTIVE CHANGES: Mode Global and Omega Diagnostics lose CEOs
Read moreTRADING UPDATES: Harvest Minerals sales jump; Quartix earnings to rise
Read moreIN BRIEF: Omega Diagnostics confirms Covid test effective on Omicron
Read more
(Sharecast News) - Omega Diagnostics updated the market on its contract with the UK Department of Health and Social Care (DHSC) to provide manufacturing capacity for Covid-19 lateral flow antigen tests on Friday, indicating it was in disagreement with the government on an alleged repayment requirement.
Read moreTRADING UPDATES: Omega disputes repayment; BWA applies for licenses
Read moreAIM WINNERS & LOSERS: Omega sinks on UK government repayment demand
Read moreOmega Diagnostics shares sink on widened loss and stifled contract
Read moreAIM WINNERS & LOSERS: DX Group sinks as annual results remain elusive
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Omega awaits approval of Visitect under new UK regulations
Read moreTRADING UPDATES: Bango to offer Microsoft 365; Petrofac prices notes
Read moreTRADING UPDATES: Strong interim results from Epwin, Bridgepoint
Read more
